Human T cell lymphotropic virus 1 manipulates interferon regulatory signals by controlling the TAK1-IRF3 and IRF4 pathways.
about
Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expressionThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisHTLV-1 Tax Functions as a Ubiquitin E3 Ligase for Direct IKK Activation via Synthesis of Mixed-Linkage Polyubiquitin ChainsSystems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy.A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels.Human T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesisHTLV-1 and innate immunity.Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection.Polymorphic Nature of Human T-Cell Leukemia Virus Type 1 Particle Cores as Revealed through Characterization of a Chronically Infected Cell Line.Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cellsDistinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9.Positive and negative regulation of type I Interferons by the human T cell leukemia virus antisense protein HBZ.Retrospective screening of microarray data to identify candidate IFN-inducible genes in a HTLV-1 transformed model.
P2860
Q24625246-D824F6CD-E84A-419C-A0F1-4AB0AF2C66B0Q26800055-F4E6355D-9049-473F-B951-C416DE6C3CFAQ28551396-A39936BC-24AF-4523-A033-52B75B15B771Q34145669-D55625D0-375B-4369-BC1A-596F97A85BB9Q34467421-8C3C9B4D-480C-4C2A-81F8-EE227E5DD475Q35090534-B38AA8E8-3008-4AB2-8414-2D8392679EFBQ35261692-3280C42F-800A-4F47-A9F2-D7371BB969C5Q35575009-B56D4E95-6147-491F-AAC9-CFE7E6BBD91DQ38700350-6490BBE9-3CAA-48EB-AC27-3CFA37EBAA53Q38798967-6E713466-BDE6-4F46-95BF-498509EAC55DQ39138332-21BCF881-C9E8-4AC9-A46E-0EE83831B660Q39557718-076061EC-7CAF-418F-A838-7415079F89E8Q40097549-D18DBA80-6FF8-4FBC-A100-BCD4CC735897Q52721823-1DB2C27B-EB20-4236-83E4-38CBC57B1309
P2860
Human T cell lymphotropic virus 1 manipulates interferon regulatory signals by controlling the TAK1-IRF3 and IRF4 pathways.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Human T cell lymphotropic viru ...... e TAK1-IRF3 and IRF4 pathways.
@en
type
label
Human T cell lymphotropic viru ...... e TAK1-IRF3 and IRF4 pathways.
@en
prefLabel
Human T cell lymphotropic viru ...... e TAK1-IRF3 and IRF4 pathways.
@en
P2093
P2860
P356
P1476
Human T cell lymphotropic viru ...... e TAK1-IRF3 and IRF4 pathways.
@en
P2093
Alaa Refaat
Ichiro Takasaki
Ikuo Saiki
Keiichi Koizumi
Shoji Yamaoka
Shunsuke Suzuki
Yoshiaki Tabuchi
P2860
P304
P356
10.1074/JBC.M109.031476
P407
P577
2009-12-02T00:00:00Z